WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.

Raccontata dacnbc.combbc.comnpr.org

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
npr.orgStai leggendo11 mesi fa

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.

originale
bbc.com11 mesi fa

Wegovy maker Novo Nordisk warns of slower profits as rivals bite

The Danish weight loss drug-maker claims "knock-off" treatments are hitting growth.

Leggi questa versione → originale
cnbc.com11 mesi fa

Novo Nordisk shares plunge after Wegovy maker names new CEO, cuts full-year guidance

Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 29 luglio 2025·cnbc.com

    Novo Nordisk shares plunge after Wegovy maker names new CEO, cuts full-year guidance

    Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance.

  2. martedì 29 luglio 2025·bbc.com

    Wegovy maker Novo Nordisk warns of slower profits as rivals bite

    The Danish weight loss drug-maker claims "knock-off" treatments are hitting growth.

  3. martedì 29 luglio 2025·npr.org

    Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

    Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to…